C. Amado Diago (Santander (Cantabria), Spain), P. Rogliani (Roma (RM), Italy), P. Paggiaro (Pisa (PI), Italy), J. Lopez-Campos Bodineau (Sevilla, Spain)
Bronchodilator response in adult-onset asthma according to age
M. Tommola (Seinäjoki and Jyväskylä, Finland), H. Won (Seoul, Republic of Korea), P. Ilmarinen (Seinäjoki, Finland), H. Jung (Seoul, Republic of Korea), L. Tuomisto (Seinäjoki, Finland), L. Lehtimäki (Tampere, Finland), O. Niemelä (Seinäjoki and Tampere, Finland), T. Kim (Seoul, Republic of Korea), H. Kankaanranta (Seinäjoki and Tampere, Finland)
|   |
Risk factors for airway remodeling and irreversible airway obstruction in Asthma
S. Graff (Liège, Belgium), C. Moermans (Liège, Belgium), M. Henket (Liège, Belgium), V. Paulus (Liège, Belgium), R. Louis (Liège, Belgium), F. Schleich (Liège, Belgium)
| |
The impact of gestation, and its interaction with asthma, on spirometry indices: a longitudinal analysis of lung function in pregnant women with and without asthma.
M. Jensen (Newcastle, Australia), A. Robijn (Newcastle, Australia), . Gibson (Newcastle, Australia), C. Oldmeadow (Newcastle, Australia), V. Murphy (Newcastle, Australia)
| |
Protocol to identify potential severe asthma in UK primary care
H. Heatley (Cambridge, United Kingdom), L. Bulathsinhala (Cambridge, United Kingdom), V. Carter (Cambridge, United Kingdom), I. Chaudhry (Cambridge, United Kingdom), N. Hosseini (Cambridge, United Kingdom), R. Murray (Cambridge, United Kingdom), S. Bosnic-Anticevich (Glebe, NSW, Australia), L. Heaney (Belfast, United Kingdom), D. Jackson (London, United Kingdom), R. Jones (Plymouth, United Kingdom), A. Menzies-Gow (London, United Kingdom), P. Pfeffer (London, United Kingdom), J. Busby (Belfast, United Kingdom), A. Kaplan (Toronto, ON, Canada), E. Van Ganse (Lyon, France), M. Belhassen (Lyon, France), C. Rhee (Seoul, Republic of Korea), D. Ryan (Edinburgh, United Kingdom), A. Bourdin (Montpellier Cedex, France), P. Gibson (Newcastle, Australia), T. Tran (Gaithersburg, MD, United States of America), J. Fitzgerald (Vancouver, Canada), M. Al-Aahmad (Kuwait, Kuwait), V. Backer (Copenhagen, Denmark), D. Price (Cambridge, United Kingdom)
| |
Under-referral of high risk asthma patients to specialist care in England
C. Bloom (London, United Kingdom), S. Walker (London, United Kingdom), J. Quint (London, United Kingdom)
| |
Severe asthma registry from the Institute for pulmonary diseases of Vojvodina: Baseline characteristics
S. Hromiš (Sremska Kamenica, Republic of Serbia), M. Dugajlic (Sremska Kamenica, Republic of Serbia), B. Zvezdin (Sremska Kamenica, Republic of Serbia), V. Kolarov (Sremska Kamenica, Republic of Serbia), J. Crnobrnja (Sremska Kamenica, Republic of Serbia), M. Jovancevic Drvenica (Sremska Kamenica, Republic of Serbia), D. Šijacic (Sremska Kamenica, Republic of Serbia)
| |
Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma
M. Wiegman (Leeuwarden, Netherlands), J. Kroes (Leeuwarden, Netherlands), A. Van Der Meer (Leeuwarden, Netherlands), R. Gijtenbeek (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
| |
Clinical differences of normal weight, over weight and obese asthma patients
B. Gemicioglu (Istanbul, Turkey), B. Musellim (Istanbul, Turkey), B. Degirmenci (Istanbul, Turkey), E. Sari (Istanbul, Turkey), E. Karabul (Istanbul, Turkey), I. Calik (Istanbul, Turkey), A. Ozgokce (Istanbul, Turkey), O. Merzifonlu (Istanbul, Turkey)
| |
Benefits from Tele-asthma management programme
O. Bronte Moreno (Galdakao, Spain), S. Dorado Arenas (Galdakao, Spain), S. Pascual Erquicia (Galdakao, Spain), I. Urrutia Landa (Galdakao, Spain), P. España Yandiola (Galdakao, Spain), M. Arrizubieta Basterrechea (Galdakao, Spain), S. Rodriguez Pedrosa (Galdakao, Spain), I. Noria Alonso (Galdakao, Spain), A. Aramburu Ojembarrena (Galdakao, Spain), T. Zabala Hernandez (Galdakao, Spain), A. Artaraz Ereño (Galdakao, Spain), L. Chasco Eguilaz (Galdakao, Spain), P. Garcia Hontoria (Galdakao, Spain), A. Jodar Samper (Galdakao, Spain)
| |
A review of diagnoses made in a Severe Asthma Service
E. Heiden (Portsmouth, United Kingdom), R. Harvey (Portsmouth, United Kingdom), R. De Vos (Portsmouth, United Kingdom), J. Gates (Portsmouth, United Kingdom), M. Jones (Portsmouth, United Kingdom), D. Lodge (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), A. Chauhan (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom)
| |
"Language" of sibilant rales in patients with asthma and relationship with degree of bronchial obstruction
I. Ponomareva (Ryazan, Russian Federation), V. Abrosimov (Ryazan , Russian Federation), S. Glotov (Ryazan , Russian Federation), Y. Petrov (Ryazan , Russian Federation), Y. Byalovsky (Ryazan , Russian Federation)
| |
Association between cough frequency, health status and Th2 inflammation in severe asthma
J. Holmes (Belfast, United Kingdom), L. Heaney (Belfast, United Kingdom), S. Birring (London, United Kingdom), H. Fletcher (London, United Kingdom), L. Mcgarvey (Belfast, United Kingdom)
| |
Variable expiratory airflow limitation: focus on catamenial asthma
R. Yatsyshyn (Ivano-Frankivsk, Ukraine), P. Gerych (Ivano-Frankivsk, Ukraine), N. Cherniuk (Ivano-Frankivsk, Ukraine), B. Doskaliuk (Ivano-Frankivsk, Ukraine), I. Popadynets (Ivano-Frankivsk, Ukraine), V. Mygovych (Ivano-Frankivsk, Ukraine)
| |
EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES.
I. Salinas Garrido (Bilbao, Spain), N. Marina Malanda (Barakaldo, Spain), E. López De Santamaría (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), V. Bustamante Madariaga (Bilbao, Spain), J. Gáldiz Iturri (Barakaldo, Spain)
| |
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
J. Soler-Cataluña (Valencia, Spain), P. Almagro (Terrassa, Barcelona, Spain), A. Huerta (Barcelona, Spain), D. Gonzalez-Segura (Barcelona, Spain), B. G. Cosío (Palma de Mallorca, Balearic Islands, Spain)
| |
A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma
S. Swaminathan (New York, United States of America), A. Gerber (Denver, United States of America), K. Qirko (New York, United States of America), N. Wysham (Vancouver, United States of America), E. Corcoran (Portland, United States of America), T. Smith (Louisville, United States of America)
| |
Asthma exacerbations with long-term follow-up: a retrospective study
N. Nagano (Tokyo, Japan), M. Iikura (Tokyo, Japan), S. Izumi (Tokyo, Japan), H. Sugiyama (Tokyo, Japan)
| |
Predicting physician decision to prescribe systemic corticosteroids following an exacerbation of airways disease
A. Halner (Oxford, United Kingdom), S. Beer (Oxford, United Kingdom), R. Russell (Oxford, United Kingdom), M. Bafadhel (Oxford, United Kingdom)
| |
EVALUATION OF OF SMALL AIRWAYS INFLAMMATORY PARAMETERS IN A GROUP OF ASTHMATIC PATIENTS
V. Bustamante Madariaga (Bilbao, Spain), I. Salinas Garrido (Bilbao, Spain), N. Marina Malanda (Baracaldo, Spain), E. López De Santa Maria Miro (Baracaldo, Spain), M. Garcia Carreira (Baracaldo, Spain), M. Mayor Alvarez (Baracaldo, Spain), J. Galdiz Iturri (Baracaldo, Spain)
| |
LSC - 2019 - Neutrophil gelatinase-associated lipocalin and IL-6 – markers predictors for exacerbations in Asthma- COPD overlap, compared to COPD and Asthma
M. Mihaylov (Sofia, Bulgaria), V. Youroukova (Sofia, Bulgaria), J. Hristova (Sofia, Bulgaria), D. Dimitrova (Sofia, Bulgaria), D. Marinova (Sofia, Bulgaria)
| |